A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancer
- 30 September 1990
- journal article
- clinical trial
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 17 (2-3) , 161-163
- https://doi.org/10.1016/0305-7372(90)90041-d
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complexBiochemistry, 1982
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- Modification of some of the toxic effects of daunomycin (NSC-82,151) by pretreatment with the antineoplastic agent ICRF 159 (NSC-129,943)Toxicology and Applied Pharmacology, 1974